

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
MLTX
MoonLake Immunotherapeuti
$9.52
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Chart
$61.99 (-84.64%)
$51.1 (-81.37%)
$48.55 (-80.39%)
$51.48 (-81.51%)
MLTX has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

MLTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MLTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MLTX Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayMLTX Earnings
The TTM reflects 12-month period, providing review of MLTX financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
MRK
87.49
+0.36%
SNY
51.64
+4.28%
LLY
827.52
+0.52%
ANAB
35.07
+3.15%
ABBV
227.99
+0.04%
What is MLTX current stock price?
What are MLTX stock strengths?
What risks are associated with MLTX stock?
When is MLTX next earnings report?
What is MLTX market cap and volume?
What is MLTX's current Stock IQ?
Should I buy MLTX stock right now?
Is MLTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for MLTX?
What does a 'Strong Sell' rating mean for MLTX?
What factors influence MLTX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
MLTX
MoonLake Immunotherapeuti
Current Price
$9.52
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Linked to MLTX
MRK
87.49
+0.36%
SNY
51.64
+4.28%
LLY
827.52
+0.52%
ANAB
35.07
+3.15%
ABBV
227.99
+0.04%
Chart
$61.99 (-84.64%)
$51.1 (-81.37%)
$48.55 (-80.39%)
$51.48 (-81.51%)
MLTX Analysts Opinion
MLTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MLTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MLTX Street view is bullish and have positive views on the near-term outlook
MLTX has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels.
MLTX Earnings
The TTM data reflects the most recent 12-month period, providing overview of MLTX financial performance.
MLTX Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
MLTX Latest Analysis
Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies | DelveInsight. Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24 Companies and 26 Therapies |. DelveInsightThe hidradenitis suppurativa market is poised for strong growth driven by increasing disease awareness earlier diagnosis and expanding treatment access. Advances in biologic and targeted therapies particularly the emergen
Thu Oct 23, 2025
MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX. announces that it is investigating claims on behalf of investors of MoonLake Immunotherapeutics (".MoonLake". or ".the Company".) (NASDAQ: ) for violations of the securities laws.INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. MoonLake'.
Tue Oct 7, 2025
Top 3 Health Care Stocks That Are Preparing To Pump In Q4. The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator which compares a stock’.s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’.s price action it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is belo
Mon Oct 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MLTX Stock trends
MLTX Stock performance
MLTX Stock analysis
MLTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.